0001209191-17-005130.txt : 20170123
0001209191-17-005130.hdr.sgml : 20170123
20170123171835
ACCESSION NUMBER: 0001209191-17-005130
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170120
FILED AS OF DATE: 20170123
DATE AS OF CHANGE: 20170123
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mast Therapeutics, Inc.
CENTRAL INDEX KEY: 0001160308
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 841318182
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 500
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 8585520866
MAIL ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 500
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: ADVENTRX PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20030613
FORMER COMPANY:
FORMER CONFORMED NAME: BIOKEYS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20010928
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Culley Brian M
CENTRAL INDEX KEY: 0001310683
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32157
FILM NUMBER: 17541694
MAIL ADDRESS:
STREET 1: 6725 MESA RIDGE ROAD
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-01-20
0
0001160308
Mast Therapeutics, Inc.
MSTX
0001310683
Culley Brian M
3611 VALLEY CENTRE DRIVE, SUITE 500
SAN DIEGO
CA
92130
1
1
0
0
CEO and Director
Restricted Stock Units
2017-01-20
4
A
0
2368194
0.00
A
Common Stock
2368194
2368194
D
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017).
/s/ Brian M. Culley
2017-01-23